Inflammatory bowel disease and coronary artery disease

Indian Journal of Gastroenterology

Volumn 28, Issue 1, 2009, Pages 28-30

  Sappati Biyyani, Raja Shekhar R ^a,b   Fahmy, Nabil M ^d   Baum, Elizabeth ^b   Nelson, Karl M ^c   King, James F ^d  

^a METROHEALTH MEDICAL CENTER   (United States)

^b Canton Medical Education Foundation   (United States)

^c AULTMAN HOSPITAL   (United States)

^d Gastroenterology and Hepatology Specialists Inc   (United States)

Author keywords

Framingham heart study; Multivariate models; Pathogenesis of atherosclerosis

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CROHN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; MEDICAL RECORD REVIEW; RATING SCALE; SEX DIFFERENCE; ULCERATIVE COLITIS;

ACUTE-PHASE PROTEINS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 67649598359     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-009-0006-3     Document Type: Article

References (10)

1. Zoccali C, Mallamaci F, Tripepi G. Inflammatory proteins as predictors of cardiovascular disease in patients with endstage renal disease. Nephrol Dial Transplant 2004;19(suppl. 5):67-72. (Pubitemid 39214203)
2. Maradit-Kremers H, Crowson CS, Nicola PJ. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. Arthritis Rheumatism 2005;52:402-411
3. Shovman O, Gilburd B, Shoenfeld Y. The role of inflammatory cytokines in the pathogenesis of sytemic Lupus erythematosus- related atherosclerosis: a novel target for treatment. J Rheumatol 2006;33:445-447 (Pubitemid 43334563)
4. Deliargyris EN, Madianos PN, Kadoma W, et al. Periodontal disease in patients with acute myocardial infarction: prevalence and contribution to elevated C-reactive protein levels. Am Heart J 2004;147:1005-1009 (Pubitemid 38880955)
5. Goggins MG, Goh J, O'Connell MA, et al. Soluble adhesion molecules in inflammatory bowel disease. Ir J Med Sci 2001;170:107-111 (Pubitemid 32701020)
6. Wilson PWF. Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 2004;27(suppl. III):III-7-11. (Pubitemid 38720189)
7. Ridker PM, Wilson PWF, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004;109:2818-2825
8. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. Inflamm Bowel Dis 2001;7:250-255 (Pubitemid 32776519)
9. Ito H. Treatment of Crohn's disease with anti-IL-6 receptor antibody. J Gastroenterol 2005;40(suppl. 16):32-34
10. Kupcova V, Turecky L, Detkova Z, et al. Changes in acute phase proteins after anti-tumor necrosis factor antibody (infliximab) treatment in patients with Crohn's disease. Physiol Res 2003;52:89-93. (Pubitemid 36356265)